Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Astrid Skarheim Onsum

Organon & Co. - Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE®(tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Sarjit Singh Gill

New Form 424B2 - UBS AG <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001839882-26-028687 <b>Size:</b> 1 MB

New Form N-2 - SOURCE CAPITAL /DE/ <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001104659-26-072168 <b>Size:</b> 1 MB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016211 <b>Size:</b> 475 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001140361-26-024743 <b>Size:</b> 438 KB

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

LTM Introduces BlueVerse™ Currency to Enable Outcome-Based Pricing in the Agentic AI Era

Smoothie King Drives Incremental Revenue and Loyalty Engagement with PAR Games in First Three Months

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Ieda Gomes Yell

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Jan Holm

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Yap Chee Keong

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Mark Gainsborough

Employee Stock Option/ Share Scheme: Grant of Awards and Transfer and Use of Treasury Shares